UniProt ID | NHRF1_HUMAN | |
---|---|---|
UniProt AC | O14745 | |
Protein Name | Na(+)/H(+) exchange regulatory cofactor NHE-RF1 | |
Gene Name | SLC9A3R1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 358 | |
Subcellular Localization |
Cytoplasm. Apical cell membrane. Endomembrane system Peripheral membrane protein. Cell projection, filopodium. Cell projection, ruffle. Cell projection, microvillus. Translocates from the cytoplasm to the apical cell membrane in a PODXL-dependent ma |
|
Protein Description | Scaffold protein that connects plasma membrane proteins with members of the ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for recycling of internalized ADRB2. Was first known to play a role in the regulation of the activity and subcellular location of SLC9A3. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. May enhance Wnt signaling. May participate in HTR4 targeting to microvilli (By similarity). Involved in the regulation of phosphate reabsorption in the renal proximal tubules. Involved in sperm capacitation. May participate in the regulation of the chloride and bicarbonate homeostasis in spermatozoa.. | |
Protein Sequence | MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSADAAAGA ------CCHHHHCCC | 34.55 | 19413330 | |
2 | Phosphorylation | ------MSADAAAGA ------CCHHHHCCC | 34.55 | 23401153 | |
15 | S-nitrosylation | GAPLPRLCCLEKGPN CCCCCEEEEECCCCC | 2.35 | 24105792 | |
16 | S-nitrosylation | APLPRLCCLEKGPNG CCCCEEEEECCCCCC | 6.96 | 24105792 | |
19 | Acetylation | PRLCCLEKGPNGYGF CEEEEECCCCCCCEE | 67.72 | 23749302 | |
32 | Acetylation | GFHLHGEKGKLGQYI EEEEECCCCCCCEEE | 66.97 | 19608861 | |
34 | Acetylation | HLHGEKGKLGQYIRL EEECCCCCCCEEEEE | 61.59 | 25953088 | |
38 | Phosphorylation | EKGKLGQYIRLVEPG CCCCCCEEEEEECCC | 6.04 | 22817900 | |
46 | Phosphorylation | IRLVEPGSPAEKAGL EEEECCCCHHHHHCC | 31.49 | 25159151 | |
50 | Ubiquitination | EPGSPAEKAGLLAGD CCCCHHHHHCCCCCC | 50.27 | 21906983 | |
50 | 2-Hydroxyisobutyrylation | EPGSPAEKAGLLAGD CCCCHHHHHCCCCCC | 50.27 | - | |
58 | Methylation | AGLLAGDRLVEVNGE HCCCCCCEEEEECCC | 39.45 | 115484969 | |
69 | Ubiquitination | VNGENVEKETHQQVV ECCCCCCHHHHHHHH | 64.73 | 24816145 | |
69 | Acetylation | VNGENVEKETHQQVV ECCCCCCHHHHHHHH | 64.73 | 25953088 | |
77 | Phosphorylation | ETHQQVVSRIRAALN HHHHHHHHHHHHHHH | 24.12 | 22817900 | |
95 | Phosphorylation | LLVVDPETDEQLQKL EEEECCCCHHHHHHH | 50.66 | 22817900 | |
101 | Ubiquitination | ETDEQLQKLGVQVRE CCHHHHHHHCHHHHH | 56.66 | 21963094 | |
156 | Phosphorylation | ELRPRLCTMKKGPSG HHHHCEECCCCCCCC | 36.30 | - | |
158 | Ubiquitination | RPRLCTMKKGPSGYG HHCEECCCCCCCCCC | 36.10 | 23503661 | |
159 | Ubiquitination | PRLCTMKKGPSGYGF HCEECCCCCCCCCCC | 66.29 | 23503661 | |
162 | Phosphorylation | CTMKKGPSGYGFNLH ECCCCCCCCCCCCCC | 54.00 | 25159151 | |
164 | Phosphorylation | MKKGPSGYGFNLHSD CCCCCCCCCCCCCCC | 23.92 | 25307156 | |
170 | Phosphorylation | GYGFNLHSDKSKPGQ CCCCCCCCCCCCCCC | 50.31 | 20873877 | |
172 | Ubiquitination | GFNLHSDKSKPGQFI CCCCCCCCCCCCCEE | 64.49 | 29967540 | |
173 | Phosphorylation | FNLHSDKSKPGQFIR CCCCCCCCCCCCEEE | 49.42 | - | |
181 | Phosphorylation | KPGQFIRSVDPDSPA CCCCEEEECCCCCHH | 26.51 | 28258704 | |
186 | Phosphorylation | IRSVDPDSPAEASGL EEECCCCCHHHHCCC | 31.25 | 21815630 | |
191 | Phosphorylation | PDSPAEASGLRAQDR CCCHHHHCCCCHHCC | 29.84 | - | |
195 | Ubiquitination | AEASGLRAQDRIVEV HHHCCCCHHCCEEEE | 22.22 | - | |
206 | S-nitrosylation | IVEVNGVCMEGKQHG EEEECCEEECCCCCC | 1.86 | 24105792 | |
210 | Acetylation | NGVCMEGKQHGDVVS CCEEECCCCCCCCEE | 26.30 | 26051181 | |
217 | Phosphorylation | KQHGDVVSAIRAGGD CCCCCCEEEEEECCC | 20.16 | 21406692 | |
226 | Phosphorylation | IRAGGDETKLLVVDR EEECCCCCEEEEEEC | 31.56 | 21406692 | |
227 | Ubiquitination | RAGGDETKLLVVDRE EECCCCCEEEEEECC | 37.46 | 24816145 | |
240 | Acetylation | RETDEFFKKCRVIPS CCHHHHHHHCCCCCC | 57.17 | 25953088 | |
240 | 2-Hydroxyisobutyrylation | RETDEFFKKCRVIPS CCHHHHHHHCCCCCC | 57.17 | - | |
241 | Ubiquitination | ETDEFFKKCRVIPSQ CHHHHHHHCCCCCCC | 23.32 | 24816145 | |
247 | Phosphorylation | KKCRVIPSQEHLNGP HHCCCCCCCHHCCCC | 36.76 | 24719451 | |
260 | Phosphorylation | GPLPVPFTNGEIQKE CCCCCCCCCCCCCCC | 35.92 | 26657352 | |
269 | Phosphorylation | GEIQKENSREALAEA CCCCCCCHHHHHHHH | 32.37 | 25159151 | |
280 | O-linked_Glycosylation | LAEAALESPRPALVR HHHHHHHCCCCHHHH | 27.36 | OGP | |
280 | Phosphorylation | LAEAALESPRPALVR HHHHHHHCCCCHHHH | 27.36 | 19664994 | |
288 | Phosphorylation | PRPALVRSASSDTSE CCCHHHHCCCCCCHH | 25.64 | 29255136 | |
290 | Phosphorylation | PALVRSASSDTSEEL CHHHHCCCCCCHHHH | 29.96 | 29255136 | |
291 | Phosphorylation | ALVRSASSDTSEELN HHHHCCCCCCHHHHH | 44.62 | 29255136 | |
293 | Phosphorylation | VRSASSDTSEELNSQ HHCCCCCCHHHHHCC | 39.73 | 22167270 | |
294 | Phosphorylation | RSASSDTSEELNSQD HCCCCCCHHHHHCCC | 33.78 | 19664994 | |
299 | Phosphorylation | DTSEELNSQDSPPKQ CCHHHHHCCCCCCCC | 48.25 | 19664994 | |
302 | Phosphorylation | EELNSQDSPPKQDST HHHHCCCCCCCCCCC | 35.15 | 19664994 | |
308 | Phosphorylation | DSPPKQDSTAPSSTS CCCCCCCCCCCCCCC | 24.79 | 23663014 | |
309 | Phosphorylation | SPPKQDSTAPSSTSS CCCCCCCCCCCCCCC | 51.37 | 23663014 | |
312 | Phosphorylation | KQDSTAPSSTSSSDP CCCCCCCCCCCCCCC | 43.73 | 23663014 | |
313 | Phosphorylation | QDSTAPSSTSSSDPI CCCCCCCCCCCCCCC | 31.11 | 23663014 | |
314 | Phosphorylation | DSTAPSSTSSSDPIL CCCCCCCCCCCCCCC | 36.64 | 26657352 | |
315 | Phosphorylation | STAPSSTSSSDPILD CCCCCCCCCCCCCCC | 29.77 | 23663014 | |
316 | Phosphorylation | TAPSSTSSSDPILDF CCCCCCCCCCCCCCH | 38.56 | 23663014 | |
317 | Phosphorylation | APSSTSSSDPILDFN CCCCCCCCCCCCCHH | 47.36 | 30278072 | |
326 | Phosphorylation | PILDFNISLAMAKER CCCCHHHHHHHHHHH | 15.92 | 20068231 | |
339 | Phosphorylation | ERAHQKRSSKRAPQM HHHHHHHHCCCCCCC | 47.44 | 17613530 | |
340 | Phosphorylation | RAHQKRSSKRAPQMD HHHHHHHCCCCCCCC | 30.14 | 17613530 | |
349 | Phosphorylation | RAPQMDWSKKNELFS CCCCCCHHHHHHHHH | 29.50 | 26074081 | |
350 | Ubiquitination | APQMDWSKKNELFSN CCCCCHHHHHHHHHC | 56.20 | 29967540 | |
351 | Ubiquitination | PQMDWSKKNELFSNL CCCCHHHHHHHHHCC | 50.57 | - | |
356 | Phosphorylation | SKKNELFSNL----- HHHHHHHHCC----- | 50.26 | 28555341 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
77 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
156 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
156 | T | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
162 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
280 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
290 | S | Phosphorylation | Kinase | GRK6 | P43250 | PhosphoELM |
302 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
339 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
340 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NHRF1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NHRF1_HUMAN !! |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-280, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280; SER-290; SER-291AND THR-293, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY. |